J. Gregory Swendsen is President of Swendsen & Company, a management company founded in 1984 that specializes in venture capital in the applied technologies. Mr. Swendsen is a founder of SuperGen, Inc. (NASDAQ: SUPG), a leading developer of anti-cancer drugs, a founder of Quark Biotech, and served on the board of AMUR Pharmaceuticals, which he financed prior to its sale to SuperGen. Mr. Swendsen has raised over $250 million for pharmaceutical and biotech companies. He currently sits on the board of Planet Biotech, and Kinemed, Inc.
